SEC Form D · filed March 28, 2024
ASLAN Pharmaceuticals Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Kathleen M. Metters · Singapore, U0DirectorNeil Graham, Mbbs, M.D., Mph · Singapore, U0DirectorAlexandre M. Kaoukhov · Singapore, U0ExecKiran Asarpota · Singapore, U0ExecRobert E. Hoffman · Singapore, U0DirectorBen M. Goodger · Singapore, U0ExecCarl Firth, Ph.D · Singapore, U0Exec · DirectorAndrew Howden · Singapore, U0DirectorStephen M. Doyle · Singapore, U0ExecDan Davidson · Southlake, TXExecRoozbeh Baharian · Chicago, ILExecAndrea D. Sandoval · Sulphur Springs, TXDirectorGlenn R. Richter · LUXEMBOURG CITY, LuxembourgExecGregory Cohen · Jacksonville, FLDirectorEvan Kominsky · Chicago, ILExec · DirectorDamien R. Mignot · LUXEMBOURG CITY, LuxembourgDirectorAlexander Sifakis · Jacksonville, FLDirectorDeborah M. Thomas · LUXEMBOURG CITY, LuxembourgExecRichard C. Cilento · Houston, TXExecVictoria Niklas · Houston, TXDirectorTheodore W. Coons, Jr · New York, NYDirectorJoe Benavides · New York, NYExecMichael B. Mccord · Austin, TXExec · DirectorKarl Gorin · St. Helier, Y9ExecRobert Quirke · London, United KingdomExecTara Duncan · St. Helier, Y9DirectorPaul Teske · Old Greenwich, CTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗